Influence of patient and tumor characteristics on therapy persistence with letrozole in postmenopausal women with advanced breast cancer: results of the prospective observational EvAluate-TM study-Reference-Cited by-同舟云学术

Influence of patient and tumor characteristics on therapy persistence with letrozole in postmenopausal women with advanced breast cancer: results of the prospective observational EvAluate-TM study

Published:2019-06-21 Issue:1 Volume:19 Page:
ISSN:1471-2407
Container-title:BMC Cancer
language:en
Short-container-title:BMC Cancer

Author:

Wallwiener Markus,Nabieva Naiba,Feisst Manuel,Fehm Tanja,de Waal Johann,Rezai Mahdi,Baier Bernd,Baake Gerold,Kolberg Hans-Christian,Guggenberger Martin,Warm Mathias,Harbeck Nadia,Wuerstlein Rachel,Deuker Jörg-Uwe,Dall Peter,Richter Barbara,Wachsmann Grischa,Brucker Cosima,Siebers Jan Willem,Popovic Milos,Kuhn Thomas,Wolf Christopher,Vollert Hans-Walter,Breitbach Georg-Peter,Janni Wolfgang,Landthaler Robert,Kohls Andreas,Rezek Daniela,Noesselt Thomas,Fischer Gunnar,Henschen Stephan,Praetz Thomas,Heyl Volker,Kühn Thorsten,Krauss Thomas,Thomssen Christoph,Hohn Andre,Tesch Hans,Mundhenke Christoph,Hein Alexander,Rauh Claudia,Bayer Christian M.,Schmidt Katja,Belleville Erik,Brucker Sara Y.,Hadji Peyman,Beckmann Matthias W.,Wallwiener Diethelm,Kümmel Sherko,Hartkopf Andreas,Fasching Peter A.^ORCID

Funder

Novartis Pharma

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Oncology

Link

http://link.springer.com/content/pdf/10.1186/s12885-019-5806-y.pdf

Reference30 articles.

1. Cardoso F, Harbeck N, Fallowfield L, Kyriakides S, Senkus E, Group EGW. Locally recurrent or metastatic breast cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2012;23(Suppl 7):vii11–9.

2. Cardoso F, Costa A, Norton L, Senkus E, Aapro M, Andre F, Barrios CH, Bergh J, Biganzoli L, Blackwell KL, et al. ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2). Breast. 2014;23(5):489–502.

3. Turner NC, Neven P, Loibl S, Andre F. Advances in the treatment of advanced oestrogen-receptor-positive breast cancer. Lancet. 2016.